Enteric-Coated Glucosinolates And Beta-Thioglucosidases
First Claim
1. A method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated chemoprotectant precursor composition, said method comprising:
- (1) enteric-coated beta-thioglucosidase particles;
(2) enteric-coated glucosinolate particles,wherein beta-thioglucosidase and glucosinolate are released from the enteric-coated beta-thioglucosidase particles and enteric-coated glucosinolate particles, respectively, in the small intestine where beta-thioglucosidase converts glucosinolate to isothiocyanate.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a particulate composition comprising enteric-coated glucosinolate and beta-thioglucosidase particles. The present invention further provides a method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated chemoprotectant precursor composition comprising enteric-coated glucosinolate and beta-thioglucosinodase particles. In another aspect, uncoated glucosinolate and beta-thioglucosinodase particles may be provided in an enteric-coated capsule. Preferably, the glucosinolate is glucoraphanin and the beta-thioglucosidase is myrosinase. The enteric coating targets the compound for release in the small intestine where beta-thioglucosinodase enzyme converts glucosinolate to chemoprotectant isothiocyanate.
120 Citations
29 Claims
-
1. A method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated chemoprotectant precursor composition, said method comprising:
-
(1) enteric-coated beta-thioglucosidase particles; (2) enteric-coated glucosinolate particles, wherein beta-thioglucosidase and glucosinolate are released from the enteric-coated beta-thioglucosidase particles and enteric-coated glucosinolate particles, respectively, in the small intestine where beta-thioglucosidase converts glucosinolate to isothiocyanate. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated capsule containing a chemoprotectant precursor composition comprising:
-
(1) beta-thioglucosidase particles; (2) glucosinolate particles, wherein beta-thioglucosidase and glucosinolate are released from the beta-thioglucosidase particles and glucosinolate particles, respectively, in the small intestine where beta-thioglucosidase converts glucosinolate to isothiocyanate. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. An enteric-coated chemoprotectant precursor composition comprising:
-
(1) about 0.5 to about 50 weight percent glucosinolate; (2) about 0.5 to about 50 weight percent beta-thioglucosidase; and (3) about 1 to about 99 weight percent composition comprising coating excipient and optionally diluent, wherein the chemoprotectant precursor composition is encapsulated with enteric coating. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24)
-
-
25. An enteric-coated capsule comprising a chemoprotectant precursor mixture, the chemoprotectant mixture comprising uncoated beta-thioglucosidase particles and uncoated glucosinolate particles in a ratio of about 1:
- 100 to about 100;
1, wherein the mixture is contained within an enteric-coated capsule. - View Dependent Claims (26, 27, 28, 29)
- 100 to about 100;
Specification